Stimulation of interleukin-13 expression by human T-cell leukemia virus type 1 oncoprotein Tax via a dually active promoter element responsive to NF-κB and NFAT

Journal of General Virology

Volumn 89, Issue 11, 2008, Pages 2788-2798

  Silbermann, Katrin ^a   Schneider, Grit ^a   Grassmann, Ralph ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; I KAPPA B; INTERLEUKIN 13; ONCOPROTEIN; TAX PROTEIN; TRANSCRIPTION FACTOR NFAT;

APOPTOSIS; ARTICLE; BINDING AFFINITY; BINDING SITE; CELL PROLIFERATION; CONTROLLED STUDY; GENE ACTIVATION; GENE ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IMMUNOBLOTTING; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; T LYMPHOCYTE ACTIVATION; TRANSACTIVATION; TRANSCRIPTION REGULATION; UPREGULATION; VIRUS REPLICATION;

DNA PRIMERS; GENE EXPRESSION REGULATION; GENE PRODUCTS, TAX; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; INTERLEUKIN-13; NF-KAPPA B; NFATC TRANSCRIPTION FACTORS; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; T-LYMPHOCYTES; TATA BOX; TRANSCRIPTIONAL ACTIVATION;

HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 56349152727     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.2008/003699-0     Document Type: Article

References (68)

1. Ahlers, J. D., Belyakov, I. M., Terabe, M., Koka, R., Donaldson, D. D., Thomas, E. K. & Berzofsky, J. A. (2002). A push-pull approach to maximize vaccine efficacy: abrogating suppression with an IL-13 inhibitor while augmenting help with granulocyte/macrophage colony-stimulating factor and CD40L. Proc Natl Acad Sci U S A 99, 13020-13025.
2. Akagi, T., Ono, H., Nyunoya, H. & Shimotohno, K. (1997). Characterization of peripheral blood T-lymphocytes transduced with HTLV-I Tax mutants with different trans-activating phenotypes. Oncogene 14, 2071-2078.
3. Bargou, R. C., Leng, C., Krappmann, D., Emmerich, F., Mapara, M. Y., Bommert, K., Royer, H. D., Scheidereit, C. & Dorken, B. (1996). High-level nuclear NF-κB and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells. Blood 87, 4340-4347.
4. Bargou, R. C., Emmerich, F., Krappmann, D., Bommert, K., Mapara, M. Y., Arnold, W., Royer, H. D., Grinstein, E., Greiner, A. & other authors (1997). Constitutive nuclear factor-κB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. J Clin Invest 100, 2961-2969.
5. Birnie, G. D. (1978). Isolation of nuclei from animal cells in culture. Methods Cell Biol 17, 13-26.
6. Chung, H. K., Young, H. A., Goon, P. K., Heidecker, G., Princler, G. L., Shimozato, O., Taylor, G. P., Bangham, C. R. & Derse, D. (2003). Activation of interleukin-13 expression in T cells from HTLV-1-infected individuals and in chronically infected cell lines. Blood 102, 4130-4136.
7. Crabtree, G. R. & Olson, E. N. (2002). NFAT signaling: choreographing the social lives of cells. Cell 109 ( Suppl.), S67-S79.
8. Deepak, P., Sanjay, K. & Acharya, A. (2007). IL-13 Rα2-mediated interleukin-13 neutralization represses in vivo progressive growth of a T-cell lymphoma. J Exp Clin Cancer Res 26, 347-352.
9. Dolganov, G., Bort, S., Lovett, M., Burr, J., Schubert, L., Short, D., McGurn, M., Gibson, C. & Lewis, D. B. (1996). Coexpression of the interleukin-13 and interleukin-4 genes correlates with their physical linkage in the cytokine gene cluster on human chromosome 5q23-31. Blood 87, 3316-3326.
10. 3 and retinoid X receptor function. Am J Physiol Endocrinol Metab 279, E213-E220.
11. Fraedrich, K., Muller, B. & Grassmann, R. (2005). The HTLV-1 Tax protein binding domain of cyclin-dependent kinase 4 (CDK4) includes the regulatory PSTAIRE helix. Retrovirology 2, 54.
12. Fujii, M., Chuhjo, T., Minamino, T., Masaaki, N., Miyamoto, K. & Seiki, M. (1995). Identification of the Tax interaction region of serum response factor that mediates the aberrant induction of immediate early genes through CArG boxes by HTLV-I Tax. Oncogene 11, 7-14.
13. Gauchat, J. F., Schlagenhauf, E., Feng, N. P., Moser, R., Yamage, M., Jeannin, P., Alouani, S., Elson, G., Notarangelo, L. D. & other authors (1997). A novel 4-kb interleukin-13 receptor alpha mRNA expressed in human B, T, and endothelial cells encoding an alternate type-II interleukin-4/interleukin-13 receptor. Eur J Immunol 27, 971-978.
14. Gessain, A., Barin, F., Vernant, J. C., Gout, O., Maurs, L., Calender, A. & de The, G. (1985). Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 2, 407-410.
15. Good, L., Maggirwar, S. B. & Sun, S. C. (1996). Activation of the IL-2 gene promoter by HTLV-I tax involves induction of NF-AT complexes bound to the CD28-responsive element. EMBO J 15, 3744-3750.
16. Good, L., Maggirwar, S. B., Harhaj, E. W. & Sun, S. C. (1997). Constitutive dephosphorylation and activation of a member of the nuclear factor of activated T cells, NF-AT1, in Tax-expressing and type I human T-cell leukemia virus-infected human T cells. J Biol Chem 272, 1425-1428.
17. Grassmann, R., Aboud, M. & Jeang, K. T. (2005). Molecular mechanisms of cellular transformation by HTLV-1 Tax. Oncogene 24, 5976-5985.
18. Grossman, W. J., Kimata, J. T., Wong, F. H., Zutter, M., Ley, T. J. & Ratner, L. (1995). Development of leukemia in mice transgenic for the tax gene of human T-cell leukemia virus type I. Proc Natl Acad Sci U S A 92, 1057-1061.
19. Hall, W. W. & Fujii, M. (2005). Deregulation of cell-signaling pathways in HTLV-1 infection. Oncogene 24, 5965-5975.
20. Haller, K., Wu, Y., Derow, E., Schmitt, I., Jeang, K. T. & Grassmann, R. (2002). Physical interaction of human T-cell leukemia virus type 1 Tax with cyclin-dependent kinase 4 stimulates the phosphorylation of retinoblastoma protein. Mol Cell Biol 22, 3327-3338.
21. Hasegawa, H., Sawa, H., Lewis, M. J., Orba, Y., Sheehy, N., Yamamoto, Y., Ichinohe, T., Tsunetsugu-Yokota, Y., Katano, H. & other authors (2006). Thymus-derived leukemia-lymphoma in mice transgenic for the Tax gene of human T-lymphotropic virus type I. Nat Med 12, 466-472.
22. Heinemann, S., Biesinger, B., Fleckenstein, B. & Albrecht, J. C. (2006). NFκB signaling is induced by the oncoprotein Tio through direct interaction with TRAF6. J Biol Chem 281, 8565-8572.
23. Hinz, M., Lemke, P., Anagnostopoulos, I., Hacker, C., Krappmann, D., Mathas, S., Dorken, B., Zenke, M., Stein, H. & Scheidereit, C. (2002). Nuclear factor κB-dependent gene expression profiling of Hodgkin's disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity. J Exp Med 196, 605-617.
24. Jeang, K. T. (2001). Functional activities of the human T-cell leukemia virus type I Tax oncoprotein: cellular signaling through NF-κB. Cytokine Growth Factor Rev 12, 207-217.
25. Jinquan, T., Frydenberg, J., Mukaida, N., Bonde, J., Larsen, C. G., Matsushima, K. & Thestrup-Pedersen, K. (1995). Recombinant human growth-regulated oncogene-alpha induces T lymphocyte chemotaxis. A process regulated via IL-8 receptors by IFN-gamma, TNF-alpha, IL-4, IL-10, and IL-13. J Immunol 155, 5359-5368.
26. Jost, P. J. & Ruland, J. (2007). Aberrant NF-κB signaling in lymphoma: mechanisms, consequences, and therapeutic implications. Blood 109, 2700-2707.
27. Kapp, U., Yeh, W. C., Patterson, B., Elia, A. J., Kagi, D., Ho, A., Hessel, A., Tipsword, M., Williams, A. & other authors (1999). Interleukin 13 is secreted by and stimulates the growth of Hodgkin and Reed-Sternberg cells. J Exp Med 189, 1939-1946.
28. Krueger, A., Fas, S. C., Giaisi, M., Bleumink, M., Merling, A., Stumpf, C., Baumann, S., Holtkotte, D., Bosch, V. & other authors (2006). HTLV-1 Tax protects against CD95-mediated apoptosis by induction of the cellular FLICE-inhibitory protein (c-FLIP). Blood 107, 3933-3939.
29. Li-Weber, M., Giaisi, M., Baumann, S., Palfi, K. & Krammer, P. H. (2004). NF-κB synergizes with NF-AT and NF-IL6 in activation of the IL-4 gene in T cells. Eur J Immunol 34, 1111-1118.
30. Lomo, J., Blomhoff, H. K., Jacobsen, S. E., Krajewski, S., Reed, J. C. & Smeland, E. B. (1997). Interleukin-13 in combination with CD40 ligand potently inhibits apoptosis in human B lymphocytes: upregulation of Bcl-xL and Mcl-1. Blood 89, 4415-4424.
31. Macián, F., García-Cózar, F., Im, S. H., Horton, H. F., Byrne, M. C. & Rao, A. (2002). Transcriptional mechanisms underlying lymphocyte tolerance. Cell 109, 719-731.
32. Manna, S. K. & Aggarwal, B. B. (1998). IL-13 suppresses TNF-induced activation of nuclear factor-κB, activation protein-1, and apoptosis. J Immunol 161, 2863-2872.
33. Mathas, S., Lietz, A., Janz, M., Hinz, M., Jundt, F., Scheidereit, C., Bommert, K. & Dorken, B. (2003). Inhibition of NF-κB essentially contributes to arsenic-induced apoptosis. Blood 102, 1028-1034.
34. Monticelli, S., Solymar, D. C. & Rao, A. (2004). Role of NFAT proteins in IL13 gene transcription in mast cells. J Biol Chem 279, 36210-36218.
35. Neuveut, C., Low, K. G., Maldarelli, F., Schmitt, I., Majone, F., Grassmann, R. & Jeang, K. T. (1998). Human T-cell leukemia virus type 1 Tax and cell cycle progression: role of cyclin D-cdk and p110Rb. Mol Cell Biol 18, 3620-3632.
36. L is up-regulated by HTLV-I and HTLV-II in vitro and in ex vivo ATLL samples. Blood 96, 275-281.
37. Niinuma, A., Higuchi, M., Takahashi, M., Oie, M., Tanaka, Y., Gejyo, F., Tanaka, N., Sugamura, K., Xie, L. & other authors (2005). Aberrant activation of the interleukin-2 autocrine loop through the nuclear factor of activated T cells by nonleukemogenic human T-cell leukemia virus type 2 but not by leukemogenic type 1 virus. J Virol 79, 11925-11934.
38. Northrop, J. P., Ho, S. N., Chen, L., Thomas, D. J., Timmerman, L. A., Nolan, G. P., Admon, A. & Crabtree, G. R. (1994). NF-AT components define a family of transcription factors targeted in T-cell activation. Nature 369, 497-502.
39. Okamoto, K., Fujisawa, J., Reth, M. & Yonehara, S. (2006). Human T-cell leukemia virus type-I oncoprotein Tax inhibits Fas-mediated apoptosis by inducing cellular FLIP through activation of NF-κB. Genes Cells 11, 177-191.
40. Okamura, H., Aramburu, J., García-Rodríguez, C., Viola, J. P., Raghavan, A., Tahiliani, M., Zhang, X., Qin, J., Hogan, P. G. & Rao, A. (2000). Concerted dephosphorylation of the transcription factor NFAT1 induces a conformational switch that regulates transcriptional activity. Mol Cell 6, 539-550.
41. Peloponese, J. M., Yeung, M. L. & Jeang, K. T. (2006). Modulation of nuclear factor-κB by human T cell leukemia virus type 1 Tax protein: implications for oncogenesis and inflammation. Immunol Res 34, 1-12.
42. Pichler, K., Kattan, T., Gentzsch, J., Kress, A. K., Taylor, G. P., Bangham, C. R. & Grassmann, R. (2008). Strong induction of 4-1BB, a growth and survival promoting costimulatory receptor, in HTLV-1-infected cultured and patients' T-cells by the viral Tax oncoprotein. Blood 111, 4741-4751.
43. Poiesz, B. J., Ruscetti, F. W., Gazdar, A. F., Bunn, P. A., Minna, J. D. & Gallo, R. C. (1980). Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A 77, 7415-7419.
44. Princler, G. L., Julias, J. G., Hughes, S. H. & Derse, D. (2003). Roles of viral and cellular proteins in the expression of alternatively spliced HTLV-1 pX mRNAs. Virology 317, 136-145.
45. Radonic, A., Thulke, S., Mackay, I. M., Landt, O., Siegert, W. & Nitsche, A. (2004). Guideline to reference gene selection for quantitative real-time PCR. Biochem Biophys Res Commun 313, 856-862.
46. Relic, B., Guicheux, J., Mezin, F., Lubberts, E., Togninalli, D., Garcia, I., van den Berg, W. B. & Guerne, P. A. (2001). IL-4 and IL-13, but not IL-10, protect human synoviocytes from apoptosis. J Immunol 166, 2775-2782.
47. Rivera, I., Harhaj, E. W. & Sun, S. C. (1998). Involvement of NF-AT in type I human T-cell leukemia virus Tax-mediated Fas ligand promoter transactivation. J Biol Chem 273, 22382-22388.
48. Romanchikova, N., Ivanova, V., Scheller, C., Jankevics, E., Jassoy, C. & Serfling, E. (2003). NFAT transcription factors control HIV-1 expression through a binding site downstream of TAR region. Immunobiology 208, 361-365.
49. Ruben, S. M., Dillon, P. J., Schreck, R., Henkel, T., Chen, C. H., Maher, M., Baeuerle, P. A. & Rosen, C. A. (1991). Isolation of a rel-related human cDNA that potentially encodes the 65-kD subunit of NF-κB. Science 251, 1490-1493.
50. Schmitt, I., Rosin, O., Rohwer, P., Gossen, M. & Grassmann, R. (1998). Stimulation of cyclin-dependent kinase activity and G1- to Sphase transition in human lymphocytes by the human T-cell leukemia/ lymphotropic virus type 1 Tax protein. J Virol 72, 633-640.
51. Serfling, E., Berberich-Siebelt, F., Chuvpilo, S., Jankevics, E., Klein-Hessling, S., Twardzik, T. & Avots, A. (2000). The role of NF-AT transcription factors in T cell activation and differentiation. Biochim Biophys Acta 1498, 1-18.
52. Sharma, S., Mamane, Y., Grandvaux, N., Bartlett, J., Petropoulos, L., Lin, R. & Hiscott, J. (2000). Activation and regulation of interferon regulatory factor 4 in HTLV type 1-infected T lymphocytes. AIDS Res Hum Retroviruses 16, 1613-1622.
53. Sharma, S., Grandvaux, N., Mamane, Y., Genin, P., Azimi, N., Waldmann, T. & Hiscott, J. (2002). Regulation of IFN regulatory factor 4 expression in human T cell leukemia virus-I-transformed T cells. J Immunol 169, 3120-3130.
54. Silbermann, K. & Grassmann, R. (2007). Human T cell leukemia type 1 Tax-induced signals in cell survival, proliferation, and transformation. Signal Transduct 7, 34-52.
55. Skinnider, B. F., Elia, A. J., Gascoyne, R. D., Trumper, L. H., von Bonin, F., Kapp, U., Patterson, B., Snow, B. E. & Mak, T. W. (2001). Interleukin 13 and interleukin 13 receptor are frequently expressed by Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood 97, 250-255.
56. Skinnider, B. F., Kapp, U. & Mak, T. W. (2002). The role of interleukin 13 in classical Hodgkin lymphoma. Leuk Lymphoma 43, 1203-1210.
57. Smith, M. R. & Greene, W. C. (1990). Identification of HTLV-I tax trans-activator mutants exhibiting novel transcriptional phenotypes. Genes Dev 4, 1875-1885.
58. Stuver, S. O., Tachibana, N., Okayama, A. & Mueller, N. E. (1996). Evaluation of morbidity among human T lymphotropic virus type 1 carriers in Miyazaki. Jpn J Infect Dis 173, 584-591.
59. Sun, S. C. & Yamaoka, S. (2005). Activation of NF-κB by HTLV-I and implications for cell transformation. Oncogene 24, 5952-5964.
60. Taguchi, H. (1989). Immunologic deficiency in HTLV-I infection. Rinsho Ketsueki 30, 1751-1754 (in Japanese).
61. Taylor, G. (2007). Molecular aspects of HTLV-I infection and adult T-cell leukaemia/lymphoma. J Clin Pathol 60, 1392-1396.
62. Terabe, M., Matsui, S., Noben-Trauth, N., Chen, H., Watson, C., Donaldson, D. D., Carbone, D. P., Paul, W. E. & Berzofsky, J. A. (2000). NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway. Nat Immunol 1, 515-520.
63. Wäldele, K., Schneider, G., Ruckes, T. & Grassmann, R. (2004). Interleukin-13 overexpression by Tax transactivation: a potential autocrine stimulus in human T-cell leukemia virus-infected lymphocytes. J Virol 78, 6081-6090.
64. Wäldele, K., Silbermann, K., Schneider, G., Ruckes, T., Cullen, B. R. & Grassmann, R. (2006). Requirement of the human T-cell leukemia virus (HTLV-1) tax-stimulated HIAP-1 gene for the survival of transformed lymphocytes. Blood 107, 4491-4499.
65. Wright, K., Kolios, G., Westwick, J. & Ward, S. G. (1999). Cytokine-induced apoptosis in epithelial HT-29 cells is independent of nitric oxide formation. Evidence for an interleukin-13-driven phosphatidylinositol 3-kinase-dependent survival mechanism. J Biol Chem 274, 17193-17201.
66. Yasunaga, J. & Matsuoka, M. (2007). Leukaemogenic mechanism of human T-cell leukaemia virus type I. Rev Med Virol 17, 301-311.
67. Yoshida, M., Seiki, M., Yamaguchi, K. & Takatsuki, K. (1984). Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc Natl Acad Sci U S A 81, 2534-2537.
68. Yu, C. R., Kirken, R. A., Malabarba, M. G., Young, H. A. & Ortaldo, J. R. (1998). Differential regulation of the Janus kinase-STAT pathway and biologic function of IL-13 in primary human NK and T cells: a comparative study with IL-4. J Immunol 161, 218-227.